Clinical Trials Browser

Phase 2/3 × Lapatinib × Breast × Clear all

NCT03500380 2024-02-20

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Phase 2/3 Unknown

Breast Diseases, Breast Neoplasms

NCT03085368 2017-07-28

A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin

Phase 2/3 Unknown

Breast Neoplasms

NCT01426880 2016-02-15

GeparSixto

Phase 2/3 Completed

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms